| Followers | 22 |
| Posts | 13146 |
| Boards Moderated | 0 |
| Alias Born | 01/16/2026 |
Thursday, January 29, 2026 4:00:18 PM
??????JADA®®????????????????
January 29, 2026 3:54 PM
Business Wire
(???????) --
?????????????????????????????????????????????????????????????(NYSE: OGN)??JADA® ?????????·?????·???????????????????????????????????????????????????????
???
JADA®?????????????????????????????????????????????????????????
??
-
???????????????
-
?????????????
-
???????????
-
??????????????
-
????????????
-
???????????????????????????????
-
???????:JADA????????????3cm??
??
-
JADA??????????????????????????????????(?????)??????????????
-
??34????????????????????34??????????????????JADA????????????????????????????????????????????????????????????
-
?????????????????????????????????????????????(PPH)/?????????????????????????????
-
JADA????????????(PPH)??????????????????????????????????
-
??????????????????????????????????????????????????????????????????????
-
????????????????????????????????????????????????????????????????????????????????????????????
JADA???????????????????????844-JADAMOM??????????
JADA???????? ????? ????????????????????????
?????????
?????(NYSE:OGN)??????????????????????????????????????????????????????????????????????????????????????????????70???????????????????????????????????????????????????????????????????140????????????????????????????????
??????????????????????????????????????????????????????????????????????www.organon.com?????????LinkedIn?Instagram?X?YouTube?TikTok?Facebook????????????
???????????
????????????????????1995???????????????????????????????????????????????????????2026??????????????????2500?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????Form 10-K??????Form 8-K??????????SEC????????????????????SEC?????????????????????????SEC???????(www.sec.gov)????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
businesswire.com????????????:https://www.businesswire.com/news/home/20260127138318/ja/
Media Contacts:
Janine Colavita
(732) 861-3806
Felicia Bisaro
(646) 703-1807
Investor Contacts:
Jennifer Halchak
(201) 275-2711
Original: ??????JADA®®????????????????
Recent OGN News
- Organon Shares Jump on Reports of Potential $12 Billion Bid from Sun Pharma • IH Market News • 04/10/2026 09:52:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:26:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:11:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:07:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:02:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:12:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:11:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:10:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:08:06 PM
- Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age • Business Wire • 03/27/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:02:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:00:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:58:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:56:43 PM
- New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis • Business Wire • 02/27/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2026 09:24:45 PM
- Organon conclut un accord pour obtenir la licence de MIUDELLA®, le dispositif intra-utérin sans hormones de Sebela Pharmaceuticals • Business Wire • 02/24/2026 01:55:00 PM
- オルガノン、セベラ・ファーマシューティカルズのホルモンフリー子宮内避妊具「MIUDELLA ® 」のライセンス契約を 締結 • Business Wire • 02/23/2026 09:36:00 PM
- Organon schließt Lizenzvereinbarung für MIUDELLA®, das hormonfreie Intrauterinpessar von Sebela Pharmaceuticals • Business Wire • 02/23/2026 08:52:00 PM
- Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device • Business Wire • 02/23/2026 12:30:00 PM
- Organon climbs 6% after audit clears company of wrongdoing • IH Market News • 02/20/2026 01:28:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 12:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 12:45:44 PM
